FDA Inspection
Damien Sanderlin, MDDamien Sanderlin, MD – FDA Inspection, Mar 29, 2012
Record Details
This FDA Inspection record concerns Damien Sanderlin, MD, with an inspection on March 29, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Damien Sanderlin, MD
- Inspection Date
- March 29, 2012
- Product Type
- Biologics
View Company Profile
ID · b6ee764f-53bb-4b09-935f-ca1c0faf0102
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 775234
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 812.100Investigator lack of informed consent
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Damien Sanderlin, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 18, 2012 | OAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Damien Sanderlin, MD
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.